Brian Gemzik

432 total citations
16 papers, 318 citations indexed

About

Brian Gemzik is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Brian Gemzik has authored 16 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Oncology. Recurrent topics in Brian Gemzik's work include Pharmacogenetics and Drug Metabolism (9 papers), Hormonal and reproductive studies (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Brian Gemzik is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Hormonal and reproductive studies (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Brian Gemzik collaborates with scholars based in United States, Sweden and Germany. Brian Gemzik's co-authors include Andrew Parkinson, A. Parkinson, Robert A. Blouin, Abhik Bandyopadhyay, Indrasish Ray Chaudhuri, Larry W. Robertson, Abdul Mutlib, Jay A. Markwalder, Hao Chen and Ronald J. Gerson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Brian Gemzik

16 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Gemzik United States 10 185 93 69 67 33 16 318
Tom Rushmore United States 13 191 1.0× 126 1.4× 193 2.8× 39 0.6× 45 1.4× 14 485
Lone L. Hansen Denmark 8 102 0.6× 57 0.6× 136 2.0× 49 0.7× 28 0.8× 9 372
Mia Sandberg Sweden 7 240 1.3× 113 1.2× 62 0.9× 64 1.0× 59 1.8× 8 343
R.W. Estabrook United States 5 263 1.4× 111 1.2× 153 2.2× 53 0.8× 33 1.0× 6 381
P E Sanders United States 12 121 0.7× 78 0.8× 214 3.1× 38 0.6× 47 1.4× 20 526
Kosea S. Frederick United States 9 130 0.7× 104 1.1× 118 1.7× 30 0.4× 20 0.6× 14 340
L. Bardou France 11 134 0.7× 39 0.4× 114 1.7× 70 1.0× 41 1.2× 24 413
Yury Kapelyukh United Kingdom 9 240 1.3× 130 1.4× 123 1.8× 41 0.6× 44 1.3× 15 355
Setsuko Komuro Japan 13 226 1.2× 194 2.1× 134 1.9× 49 0.7× 27 0.8× 34 511
Morio Fukuhara Japan 11 194 1.0× 97 1.0× 128 1.9× 44 0.7× 39 1.2× 35 438

Countries citing papers authored by Brian Gemzik

Since Specialization
Citations

This map shows the geographic impact of Brian Gemzik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gemzik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gemzik more than expected).

Fields of papers citing papers by Brian Gemzik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gemzik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gemzik. The network helps show where Brian Gemzik may publish in the future.

Co-authorship network of co-authors of Brian Gemzik

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Gemzik. A scholar is included among the top collaborators of Brian Gemzik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Gemzik. Brian Gemzik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ruepp, Stefan, Evan B. Janovitz, Joseph B. Santella, et al.. (2018). Assessing the risk of drug crystallization in vivo. Journal of Pharmacological and Toxicological Methods. 96. 1–8. 2 indexed citations
2.
Otieno, Monicah A., Evan B. Janovitz, William N. Washburn, et al.. (2016). Mechanisms for Hepatobiliary Toxicity in Rats Treated with an Antagonist of Melanin Concentrating Hormone Receptor 1 (MCHR1). Toxicological Sciences. 155(2). 379–388. 4 indexed citations
3.
Muller, Patrick, Donna M. Dambach, Brian Gemzik, et al.. (2015). Integrated risk assessment of suicidal ideation and behavior in drug development. Drug Discovery Today. 20(9). 1135–1142. 10 indexed citations
4.
Dieter, Matthew Z., David M. Nelson, Linda E. Watson, et al.. (2009). Hepatobiliary Disposition of Thyroid Hormone in Mrp2-Deficient TR− Rats: Reduced Biliary Excretion of Thyroxine Glucuronide Does Not Prevent Xenobiotic-Induced Hypothyroidism. Toxicological Sciences. 108(2). 482–491. 23 indexed citations
5.
Car, Bruce D., Oliver Flint, Jennifer L. Price, et al.. (2009). Tanespimycin Reverses Bortezomib-Induced Inhibition of Granulopoiesis.. Blood. 114(22). 3846–3846. 3 indexed citations
6.
Mutlib, Abdul, Ronald J. Gerson, Paul C. Meunier, et al.. (2000). The Species-Dependent Metabolism of Efavirenz Produces a Nephrotoxic Glutathione Conjugate in Rats. Toxicology and Applied Pharmacology. 169(1). 102–113. 62 indexed citations
7.
Bandyopadhyay, Abhik, Indrasish Ray Chaudhuri, Larry W. Robertson, et al.. (1993). Expression of a Male-Specific Cytochrome P450 Isozyme (CYP2C11) in fa/fa Zucker Rats: Effect of Phenobarbital Treatment. Archives of Biochemistry and Biophysics. 307(2). 386–390. 9 indexed citations
8.
Blouin, Robert A., Abhik Bandyopadhyay, Indrasish Ray Chaudhuri, et al.. (1993). Cytochrome P450 2B Enzyme (CYP2B) Induction Defect Following Phenobarbital Treatment in the fa/fa Zucker Rat: Molecular Characterization. Archives of Biochemistry and Biophysics. 303(2). 313–320. 23 indexed citations
9.
Gemzik, Brian, et al.. (1992). Regulation of two electrophoretically distinct proteins recognized by antibody against rat liver cytochrome P450 3A1. Journal of Biochemical Toxicology. 7(1). 43–52. 22 indexed citations
10.
Gemzik, Brian, et al.. (1992). Hydroxylation of 5α-androstane-3β,17β-diol by rat prostate microsomes: Effects of antibodies and chemical inhibitors of cytochrome P450 enzymes. Archives of Biochemistry and Biophysics. 296(2). 355–365. 9 indexed citations
11.
Gemzik, Brian & Andrew Parkinson. (1992). Hydroxylation of 5α-androstane-3β,17β-diol by rat prostate microsomes: Potent inhibition by imidazole-type antimycotic drugs and lack of inhibition by steroid 5α-reductase inhibitors. Archives of Biochemistry and Biophysics. 296(2). 366–373. 8 indexed citations
12.
Gemzik, Brian, et al.. (1992). Species differences in 5α-androstane-3β,17β-diol hydroxylation by rat, monkey, and human prostate microsomes. Archives of Biochemistry and Biophysics. 296(2). 374–383. 16 indexed citations
13.
Gemzik, Brian, et al.. (1991). Species Differences in the Toxicity and Cytochrome P450 IIIA-Dependent Metabolism of Digitoxin. Molecular Pharmacology. 40(5). 859–867. 35 indexed citations
14.
Parkinson, Andrew & Brian Gemzik. (1991). [23] Production and purification of antibodies against rat liver P450 enzymes. Methods in enzymology on CD-ROM/Methods in enzymology. 206. 233–245. 43 indexed citations
15.
Bullock, Peter L., Brian Gemzik, Daniel Johnson, Thomas K. H. Chang, & A. Parkinson. (1991). Evidence from dwarf rats that growth hormone may not regulate the sexual differentiation of liver cytochrome P450 enzymes and steroid 5 alpha-reductase.. Proceedings of the National Academy of Sciences. 88(12). 5227–5231. 17 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tom Rushmore Breakdown of academic impact, for papers by Lone L. Hansen Breakdown of academic impact, for papers by Mia Sandberg Breakdown of academic impact, for papers by R.W. Estabrook Breakdown of academic impact, for papers by P E Sanders Breakdown of academic impact, for papers by Kosea S. Frederick Breakdown of academic impact, for papers by L. Bardou Breakdown of academic impact, for papers by Yury Kapelyukh Breakdown of academic impact, for papers by Setsuko Komuro Breakdown of academic impact, for papers by Morio Fukuhara
Rankless by CCL
2026